Devices and Heart Rhythm Management
At a Glance
In LMNA-related cardiomyopathy, an ICD may be considered instead of a pacemaker because it can both support a slow heartbeat and treat life-threatening fast rhythms. CRT, anticoagulation for AFib, or ablation may be added based on individual risk and heart function.
For many people with LMNA-related cardiomyopathy, managing the heart’s “electrical wiring” is just as important as managing its pumping power. Because this condition often causes the heart’s internal timer to slow down (conduction disease) while also increasing the risk of “short circuits” (arrhythmias), your medical team may recommend specialized devices to keep your heart in rhythm and protected [1][2].
Why an ICD is Discussed Over a Pacemaker
In many other heart conditions, if a patient’s heart beats too slowly, they receive a standard pacemaker. However, for LMNA-related disease, your care team will often discuss an ICD-capable system (implantable cardioverter-defibrillator) even if the only current problem is a slow heart rate [1][3].
- Pacing vs. Protection: A standard pacemaker can speed up a slow heart, but it cannot stop a dangerously fast rhythm.
- Disease Progression: Because LMNA-related disease can progress to cause life-threatening rapid rhythms (ventricular tachycardia or ventricular fibrillation), an ICD-capable system provides a “safety net” [1][4].
- Avoiding “Upgrades”: Research shows that many LMNA patients who get a pacemaker eventually need to have it “upgraded” to an ICD as the disease advances [1]. Choosing an ICD from the start can prevent the need for a second surgery later on.
- Device Risks: It is important to know that ICDs carry risks, including infection, lead complications, inappropriate shocks (shocks delivered when they aren’t needed), and the need for periodic generator replacement. This is an individualized electrophysiology decision based on shared risk assessment.
Cardiac Resynchronization Therapy (CRT)
If your heart’s pumping power has decreased and its electrical signals have become uncoordinated, your doctor may recommend CRT (Cardiac Resynchronization Therapy) [5][6].
Often called a “biventricular” device, CRT uses a third wire to help the left and right sides of your heart squeeze at exactly the same time. This is considered based on guideline criteria involving persistent symptoms despite appropriate therapy, a widened electrical pattern (such as Left Bundle Branch Block), and your anticipated ventricular pacing burden [5][7]. CRT can improve the heart’s efficiency, reduce symptoms of heart failure, and in some cases, help the heart muscle partially recover its strength [7][8].
Managing Atrial Fibrillation (AFib)
Atrial fibrillation (AFib)—an irregular and often rapid heart rhythm in the upper chambers—is very common in LMNA-related cardiomyopathy and often appears early in the disease [9][10].
- Stroke Risk: The main danger of AFib is that it can allow blood to pool and form clots, which can lead to a stroke.
- Anticoagulation: Your doctor will use a tool called the CHA2DS2-VASc score to determine if you need blood thinners (anticoagulants) [11][12]. While emerging evidence suggests some LMNA variants (like those in the Ig-Domain) may have unique thromboembolic associations, this is a topic for shared decision-making. Your doctor will weigh your stroke risk against the risk of bleeding before recommending these medications. Never start or stop blood thinners on your own [13].
The Challenges of VT Ablation
If you experience frequent episodes of rapid heart rhythms from the bottom chambers (ventricular tachycardia or VT), your doctor might discuss a procedure called catheter ablation. In this procedure, a specialist (electrophysiologist) uses heat or cold to destroy the tiny area of heart tissue causing the “short circuit” [14].
However, it is important to know that VT ablation is often more challenging in LMNA-related disease than in other conditions. This is because the fibrosis (scar tissue) in LMNA hearts is often located deep within the heart wall or in the septum (the wall between the chambers), making it harder to reach and treat effectively [14][15]. Because of high recurrence rates, ablation is usually seen as a way to reduce the number of ICD shocks rather than a “cure” for the underlying rhythm risk [14]. Individuals with frequent rhythm issues are often monitored closely by advanced heart failure and transplant teams to ensure they have every support option available [16][17].
Life with a Device
- Generator Replacement: Your device’s battery will naturally deplete over time. You will need a simple procedure for generator replacement at a variable interval depending on the device type and your pacing burden.
- If You Get Shocked: If you receive a single shock and feel fine, contact your clinic to have the device checked. If you receive multiple shocks, or feel chest pain or faint, call emergency services immediately and do not drive yourself.
Common questions in this guide
Why might someone with LMNA cardiomyopathy need an ICD instead of a pacemaker?
When is CRT used for LMNA-related cardiomyopathy?
If I develop atrial fibrillation, will I need a blood thinner?
Can catheter ablation cure ventricular tachycardia in LMNA cardiomyopathy?
What should I do if my implanted defibrillator shocks me?
How often will an implanted heart device need a battery replacement?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Why are you recommending an ICD rather than a standard pacemaker for my heart block?
- 2.What is my estimated 5-year risk for a serious heart rhythm event, and how does that affect my device choice?
- 3.If I develop atrial fibrillation, what is my specific risk for stroke, and should I start anticoagulants even if my CHA2DS2-VASc score is low?
- 4.Does my heart's electrical pattern (QRS duration) suggest that I would benefit from 'biventricular' pacing or CRT?
- 5.If I experience 'shocks' from my ICD, what is our plan for managing those rhythms? Are medications or ablation an option?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Timing of pacemaker and ICD implantation in LMNA mutation carriers.
Ollila LH, Nikus K, Parikka H, et al.
Open heart 2021; (8(1)) doi:10.1136/openhrt-2021-001622.
PMID: 33893211 - 2
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery-Dreifuss Muscular Dystrophies: A Systematic Review of the Literature.
Valenti AC, Albini A, Imberti JF, et al.
Biology 2022; (11(4)) doi:10.3390/biology11040530.
PMID: 35453731 - 3
Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry.
Nakajima K, Aiba T, Makiyama T, et al.
Circulation journal : official journal of the Japanese Circulation Society 2018; (82(11)):2707-2714 doi:10.1253/circj.CJ-18-0339.
PMID: 30078822 - 4
The subcutaneous ICD for prevention of sudden cardiac death: Current evidence and future directions.
Steffel J
Pacing and clinical electrophysiology : PACE 2020; (43(12)):1421-1427 doi:10.1111/pace.14066.
PMID: 32896919 - 5
The response to cardiac resynchronization therapy in LMNA cardiomyopathy.
Sidhu K, Castrini AI, Parikh V, et al.
European journal of heart failure 2022; (24(4)):685-693 doi:10.1002/ejhf.2463.
PMID: 35229420 - 6
The role of early cardiac resynchronization therapy implantation in dilated cardiomyopathy patients with narrow QRS carrying lamin A/C mutation.
Blich M, Darawsha W, Eyal A, et al.
American journal of cardiovascular disease 2024; (14(1)):47-53.
PMID: 38495409 - 7
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.
Chung MK, Patton KK, Lau CP, et al.
Journal of arrhythmia 2023; (39(5)):681-756 doi:10.1002/joa3.12872.
PMID: 37799799 - 8
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial.
Merkely B, Hatala R, Wranicz JK, et al.
European heart journal 2023; (44(40)):4259-4269 doi:10.1093/eurheartj/ehad591.
PMID: 37632437 - 9
Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy.
Tremblay-Gravel M, Ichimura K, Picard K, et al.
Circulation. Genomic and precision medicine 2023; (16(1)):e003480 doi:10.1161/CIRCGEN.121.003480.
PMID: 36548481 - 10
A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
Glöcklhofer CR, Steinfurt J, Franke G, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(12)):2003-2013 doi:10.1093/europace/euy127.
PMID: 29947763 - 11
Heart Failure and Stroke.
Schumacher K, Kornej J, Shantsila E, Lip GYH
Current heart failure reports 2018; (15(5)):287-296 doi:10.1007/s11897-018-0405-9.
PMID: 30062623 - 12
[Stroke prophylaxis in atrial fibrillation : When, how and for whom?]
Maurer T, Sohns C
Herz 2017; (42(4)):373-379 doi:10.1007/s00059-017-4568-z.
PMID: 28439617 - 13
Variant-Specific Late Gadolinium Enhancement Patterns Influence Clinical Outcomes in LMNA-Related Cardiomyopathy.
Castrichini M, Garmany R, Siontis KC, et al.
Journal of the American Heart Association 2025; (14(15)):e041230 doi:10.1161/JAHA.124.041230.
PMID: 40689545 - 14
Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single-Arm Meta-Analysis.
Castrichini M, Ferreira Felix I, Karlinski Vizentin V, et al.
Journal of cardiovascular electrophysiology 2026; (37(2)):268-274 doi:10.1111/jce.70193.
PMID: 41331778 - 15
Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy.
Kumar S, Androulakis AF, Sellal JM, et al.
Circulation. Arrhythmia and electrophysiology 2016; (9(8)).
PMID: 27506821 - 16
Management of monomorphic ventricular tachycardia electrical storm in structural heart disease.
AlKalbani A, AlRawahi N
Journal of the Saudi Heart Association 2019; (31(3)):135-144 doi:10.1016/j.jsha.2019.05.001.
PMID: 31198398 - 17
Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A/C gene mutations.
Hasebe Y, Fukuda K, Nakano M, et al.
Journal of cardiology 2019; (74(5)):451-459 doi:10.1016/j.jjcc.2019.03.019.
PMID: 31060954
This page is for informational purposes only and does not constitute medical advice. Decisions about an ICD, CRT, blood thinners, or ablation should be made with your cardiology and electrophysiology team.
Get notified when new evidence is published on Familial dilated cardiomyopathy with conduction defect due to LMNA mutation.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.